In-vitro activity of cefiderocol, cefepime/zidebactam, cefepime/enmetazobactam, omadacycline, eravacycline and other comparative agents against carbapenem-nonsusceptible Enterobacterales: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2017–2020
- 21 June 2021
- journal article
- research article
- Published by Elsevier BV in International Journal of Antimicrobial Agents
- Vol. 58 (3), 106377
- https://doi.org/10.1016/j.ijantimicag.2021.106377
Abstract
No abstract availableKeywords
Funding Information
- National Taiwan University Hospital
This publication has 18 references indexed in Scilit:
- Avibactam Sensitizes Carbapenem-Resistant NDM-1–Producing Klebsiella pneumoniae to Innate Immune ClearanceThe Journal of Infectious Diseases, 2019
- The Infectious Diseases Society of America’s 10 × ’20 Initiative (10 New Systemic Antibacterial Agents US Food and Drug Administration Approved by 2020): Is 20 × ’20 a Possibility?Clinical Infectious Diseases, 2019
- Novel β-lactam-β-lactamase inhibitor combinations: expectations for the treatment of carbapenem-resistant Gram-negative pathogensExpert Opinion on Drug Metabolism & Toxicology, 2019
- Carbapenem-Resistant Enterobacteriaceae Infections: Taiwan AspectsFrontiers in Microbiology, 2018
- Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosisThe Lancet Infectious Diseases, 2018
- In Vitro Activity of the Siderophore Cephalosporin, Cefiderocol, against Carbapenem-Nonsusceptible and Multidrug-Resistant Isolates of Gram-Negative Bacilli Collected Worldwide in 2014 to 2016Antimicrobial Agents and Chemotherapy, 2018
- Comparison of synergism between colistin, fosfomycin and tigecycline against extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolates or with carbapenem resistanceJournal of Microbiology, Immunology and Infection, 2017
- In Vitro Activity of the Siderophore Cephalosporin, Cefiderocol, against a Recent Collection of Clinically Relevant Gram-Negative Bacilli from North America and Europe, Including Carbapenem-Nonsusceptible Isolates (SIDERO-WT-2014 Study)Antimicrobial Agents and Chemotherapy, 2017
- In Vitro Activity of Eravacycline against Carbapenem-Resistant Enterobacteriaceae and Acinetobacter baumanniiAntimicrobial Agents and Chemotherapy, 2016
- Antibiotic resistance in Enterobacteriaceae: mechanisms and clinical implicationsBMJ, 2016